Why Krystal Biotech, Inc. (KRYS) stock moved
Krystal Biotech, Inc. (KRYS) shares rose 2.8% to $346.58 at the August 21, 2026 close, a moderate gain from the prior close of $337.02. That close is the latest confirmed price for KRYS; a live quote was not available. BestStocks flagged the session as a major change for KRYS. The move is tied to price move up. Below, we break down what changed for KRYS, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
KRYS climbed 2.8% to $346.58
Krystal Biotech, Inc. (KRYS) moved +2.71% from $337.44 to $346.58 on 2026-08-21. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was 1.8x the 5-day average, indicating modestly elevated interest. KRYS earnings are scheduled for 2026-11-02 (consensus EPS estimate $1.86); monitor the announcement for earnings surprise and guidance.
What it means for Krystal Biotech, Inc. investors
For Krystal Biotech, Inc. investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Material positive event; Positive 2.8% session move. Weighing against that: Krystal Biotech shares fell 6.42% to $343.30, with volume running at 0.56x the historical average for this time of day; Krystal Biotech, Inc. (KRYS) moved -6.61% from $363.44 to $339.43 on 2026-07-14. BestStocks rates the overall signal quality weak (39/100). With earnings roughly 70 days out, the next report is the most likely near-term test of the move.
KRYS price reaction
KRYS last traded at $346.58, up $9.56 (+2.84%) from the previous close of $337.02. Over the past month the stock has ranged between $312.57 and $366.85, and it currently sits about 63% of the way up that band.
The bull and bear case for KRYS stock
Weighing the constructive signals against the risks, here is how the bull and bear case for Krystal Biotech, Inc. (KRYS) lines up on the latest data.
The bullish case
- Material positive event.
- Positive 2.8% session move.
- Krystal Biotech, Inc. (KRYS) moved +3.19% from $314.73 to $324.77 on 2026-08-04.
The bearish case
- Krystal Biotech shares fell 6.42% to $343.30, with volume running at 0.56x the historical average for this time of day.
- Krystal Biotech, Inc. (KRYS) moved -6.61% from $363.44 to $339.43 on 2026-07-14.
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Previous notable changes for KRYS
Frequently asked questions about KRYS
Why did Krystal Biotech, Inc. (KRYS) stock move?
KRYS rose 2.8% to $346.58. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did KRYS stock rise?
KRYS gained 2.84% ($9.56) versus the prior close of $337.02, last trading at $346.58.
When is Krystal Biotech, Inc.'s next earnings date?
KRYS's next earnings report is scheduled for 2026-11-02 — about 70 days away.
How BestStocks tracks KRYS
This page is generated automatically by BestStocks' change-detection system after price move up was detected and verified against independent data sources. It draws on 17 tracked change events for KRYS, cross-checked against the data sources listed below. A live intraday quote was not available, so price and volume figures are the confirmed end-of-day close from August 21, 2026 — not the current price — and the percentage move is that session's. They refresh once live quotes resume. For companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.